Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: Gynecol Oncol. 2013 Jun 14;130(3):452–456. doi: 10.1016/j.ygyno.2013.06.009

Figure 2.

Figure 2

Kaplan-Meier analysis for the optimal classification and regression tree subgroups. Five-year overall survival rates were: 90.9% (95% CI: 88.6-92.7%) for stage I patients, 82.6% (95% CI: 76.2-87.4%) for stage II-IV & grade 1/2 patients, and 46.9% (95% CI: 40.6-52.9%) for stage II-IV & grade 3 patients.